Alternative-splicing-based bicistronic vectors for ratio-controlled protein expression and application to recombinant antibody production
Open Access
- 3 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 37 (20), e134
- https://doi.org/10.1093/nar/gkp716
Abstract
In the last decade polycistronic vectors have become essential tools for both basic science and gene therapy applications. In order to co-express heterologous polypeptides, different systems have been developed from Internal Ribosome Entry Site (IRES) based vectors to the use of the 2A peptide. Unfortunately, these methods are not fully suitable for the efficient and reproducible modulation of the ratio between the proteins of interest. Here we describe a novel bicistronic vector type based on the use of alternative splicing. By modifying the consensus sequence that governs splicing, we demonstrate that the ratio between the synthesized proteins could easily vary from 1 : 10 to 10 : 1. We have established this system with luciferase genes and we extended its application to the production of recombinant monoclonal antibodies. We have shown that these vectors could be used in several typical cell lines with similar efficiencies. We also present an adaptation of these vectors to hybrid alternative splicing/IRES constructs that allow a ratio-controlled expression of proteins of interest in stably transfected cell lines.Keywords
This publication has 23 references indexed in Scilit:
- An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoformNucleic Acids Research, 2008
- Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry siteProtein Engineering, Design and Selection, 2007
- Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectivesBiotechnology Letters, 2007
- A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodiesJournal of Immunological Methods, 2007
- Production of anti-CD2 chimeric antibody by recombinant animal cellsJournal of Bioscience and Bioengineering, 2004
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- Control of the Vascular Endothelial Growth Factor Internal Ribosome Entry Site (IRES) Activity and Translation Initiation by Alternatively Spliced Coding SequencesJournal of Biological Chemistry, 2004
- Kinetic Model of BiP- and PDI-mediated Protein Folding and AssemblyJournal of Theoretical Biology, 2002
- New Vascular Endothelial Growth Factor Isoform Generated by Internal Ribosome Entry Site-Driven CUG Translation InitiationMolecular Endocrinology, 2001
- Assembly of Immunoglobulin Light Chains as a Prerequisite for SecretionJournal of Biological Chemistry, 1997